---
figid: PMC3766375__nihms473496f3
figlink: /pmc/articles/PMC3766375/figure/F3/
number: F3
caption: PCa cancer cells show high rates of de novo lipid synthesis and the enzymes
  belonging to the pathway are regulated by oncogenic signals. Growth factor-activated
  PI3K-Akt or hypoxia-induced HIF stimulates glucose uptake and hexokinases to promote
  glycolysis, providing more synthetic precursors for FA synthesis. Akt also activates
  the lipogenic enzyme activity and expression through direct phosphorylation or SREBP-mediated
  transcription of lipogenic genes. Activation of E2F following loss of the retinoblastoma
  (Rb) protein increases expression of SREBPs and their target genes. The tumor suppressor
  p53 plays a role in glucose uptake, pentose phosphate pathway, transcription of
  lipogenic genes, and anaplerosis of citrate. Mutant p53 (p53mut) also increases
  the expression of genes within the cholesterol biosynthesis (mevalonate). The tumor
  suppressor LKB1-AMPK axis, activated in response to low cellular energy levels,
  inhibits de novo lipogenesis through direct inhibition of ACC and SREBP-1. Myc promotes
  citrate anaplerosis through increasing glutamine transporters and glutaminase 2
  expression. The activity and expression of lipogenic enzyme, ACLY, ACC, and FASN
  are also regulated at multiple levels through mTORC1 and mitogen-activated protein
  kinases (MAPKs). IDH1, isocitrate dehydrogenase 1; pRB, retinoblastoma 1; Glut,
  Glucose transporter; FBP, Fructose-1,6-bisphosphate; PEP, phosphoenolpyruvate; HK,
  Hexokinase; G6PDH, Glucose-6-phosphate dehydrogenase; PFK, Phospho-fructokinase;
  PKM2, Tumor-specific pyruvate kinase M2; LDHA, Lactate dehydrogenase A; HIF, Hypoxia-inducible
  factor; AMPK, AMP-activated protein kinase; PI3K, Phosphatidylinositol 3-kinase;
  MAPK, Mitogen activated protein kinase; mTOR, Mammalian target of rapamycin; E2F,
  DNA-binding transcription factor; SREBP-1, Sterol-regulatory element-binding protein-1;
  TCA cycle, tricarboxylic acid cycle; OAA, Oxaloacetate; Mal, Malate; ME, Malic enzyme;
  αKG, α-ketoglutarate; ACLY, ATP citrate lyase; ACC, Acetyl-CoA carboxylase; FASN,
  Fatty acid synthase; HMGCR, HMG-CoA reductase; NADPH, Nicotinamide adenine dinucleotide
  phosphate; Glt, glutamate.
pmcid: PMC3766375
papertitle: The fat side of Prostate Cancer.
reftext: Giorgia Zadra, et al. Biochim Biophys Acta. ;1831(10):1518-1532.
pmc_ranked_result_index: '71832'
pathway_score: 0.9534803
filename: nihms473496f3.jpg
figtitle: Fat side of Prostate Cancer
year: ''
organisms: Homo sapiens
ndex: fd90331f-deee-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3766375__nihms473496f3.html
  '@type': Dataset
  description: PCa cancer cells show high rates of de novo lipid synthesis and the
    enzymes belonging to the pathway are regulated by oncogenic signals. Growth factor-activated
    PI3K-Akt or hypoxia-induced HIF stimulates glucose uptake and hexokinases to promote
    glycolysis, providing more synthetic precursors for FA synthesis. Akt also activates
    the lipogenic enzyme activity and expression through direct phosphorylation or
    SREBP-mediated transcription of lipogenic genes. Activation of E2F following loss
    of the retinoblastoma (Rb) protein increases expression of SREBPs and their target
    genes. The tumor suppressor p53 plays a role in glucose uptake, pentose phosphate
    pathway, transcription of lipogenic genes, and anaplerosis of citrate. Mutant
    p53 (p53mut) also increases the expression of genes within the cholesterol biosynthesis
    (mevalonate). The tumor suppressor LKB1-AMPK axis, activated in response to low
    cellular energy levels, inhibits de novo lipogenesis through direct inhibition
    of ACC and SREBP-1. Myc promotes citrate anaplerosis through increasing glutamine
    transporters and glutaminase 2 expression. The activity and expression of lipogenic
    enzyme, ACLY, ACC, and FASN are also regulated at multiple levels through mTORC1
    and mitogen-activated protein kinases (MAPKs). IDH1, isocitrate dehydrogenase
    1; pRB, retinoblastoma 1; Glut, Glucose transporter; FBP, Fructose-1,6-bisphosphate;
    PEP, phosphoenolpyruvate; HK, Hexokinase; G6PDH, Glucose-6-phosphate dehydrogenase;
    PFK, Phospho-fructokinase; PKM2, Tumor-specific pyruvate kinase M2; LDHA, Lactate
    dehydrogenase A; HIF, Hypoxia-inducible factor; AMPK, AMP-activated protein kinase;
    PI3K, Phosphatidylinositol 3-kinase; MAPK, Mitogen activated protein kinase; mTOR,
    Mammalian target of rapamycin; E2F, DNA-binding transcription factor; SREBP-1,
    Sterol-regulatory element-binding protein-1; TCA cycle, tricarboxylic acid cycle;
    OAA, Oxaloacetate; Mal, Malate; ME, Malic enzyme; αKG, α-ketoglutarate; ACLY,
    ATP citrate lyase; ACC, Acetyl-CoA carboxylase; FASN, Fatty acid synthase; HMGCR,
    HMG-CoA reductase; NADPH, Nicotinamide adenine dinucleotide phosphate; Glt, glutamate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAG1
  - E2F3
  - PIK3CD
  - E2F1
  - E2F7
  - ACACB
  - E2F2
  - PRKAB2
  - PTEN
  - PRKAA2
  - PIK3CB
  - PIK3R3
  - PRKAA1
  - PKM
  - MTOR
  - RPTOR
  - P4HB
  - AKT2
  - PRKAB1
  - PRKAG2
  - PRKAG3
  - PIK3R4
  - PIK3CA
  - MAPK9
  - ACACA
  - MAPK10
  - MAPK12
  - SLC2A1
  - PIK3CG
  - E2F4
  - E2F5
  - PFKM
  - MAPK8
  - PIK3R6
  - FBP1
  - PIK3R5
  - AKT3
  - IDH1
  - ACLY
  - MAPK13
  - MAPK11
  - E2F6
  - E2F8
  - AKT1
  - SREBF1
  - TP53
  - PAEP
  - FASN
  - MAPK1
  - MAPK3
  - STK11
  - HIF1A
  - MYC
  - LDHA
  - MAPK14
  - MAL
  - HMGCR
  - 6-P-gluconolactone
  - 6P-gluconate
  - Glucose
  - Glutamine
  - isocitrate
  - phosphate
  - Pyruvate
  - Ribose
  - Lactate
  - Cancer
genes:
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: PKM2
  symbol: PKM2
  source: hgnc_prev_symbol
  hgnc_symbol: PKM
  entrez: '5315'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Raptor
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: Git.
  symbol: GIT
  source: hgnc_alias_symbol
  hgnc_symbol: P4HB
  entrez: '5034'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: GLUT
  symbol: GLUT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: PFK1
  symbol: PFK-1
  source: hgnc_alias_symbol
  hgnc_symbol: PFKM
  entrez: '5213'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: FBP
  symbol: FBP
  source: hgnc_prev_symbol
  hgnc_symbol: FBP1
  entrez: '2203'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: IDH1
  symbol: IDH1
  source: hgnc_symbol
  hgnc_symbol: IDH1
  entrez: '3417'
- word: AÇLY
  symbol: ACLY
  source: hgnc_symbol
  hgnc_symbol: ACLY
  entrez: '47'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: SREBP1
  symbol: SREBP1
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PEP
  symbol: PEP
  source: hgnc_alias_symbol
  hgnc_symbol: PAEP
  entrez: '5047'
- word: FASN
  symbol: FASN
  source: hgnc_symbol
  hgnc_symbol: FASN
  entrez: '2194'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: LKB1
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: HIF-1a
  symbol: HIF-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: LDHA
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Mal
  symbol: MAL
  source: hgnc_symbol
  hgnc_symbol: MAL
  entrez: '4118'
- word: HMGCR
  symbol: HMGCR
  source: hgnc_symbol
  hgnc_symbol: HMGCR
  entrez: '3156'
chemicals:
- word: 6-P-gluconolactone
  source: MESH
  identifier: C010730
- word: 6P-gluconate
  source: MESH
  identifier: D005942
- word: Glucose
  source: MESH
  identifier: D005947
- word: Glutamine
  source: MESH
  identifier: D005973
- word: isocitrate
  source: MESH
  identifier: D007523
- word: phosphate
  source: MESH
  identifier: D010710
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Ribose
  source: MESH
  identifier: D012266
- word: Lactate
  source: MESH
  identifier: D019344
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3766375__F3
redirect_from: /figures/PMC3766375__F3
figtype: Figure
---
